David V Conti

Works at

Sources: reporter.nih.gov

Grants and prizes

  • National Cancer Institute

    U01, Leveraging Prospective Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores, U01CA261339, 2026–2027, 27 Aug 2026

  • National Cancer Institute

    R01, Metabolomic mechanisms contributing to prostate cancer risk across multiple populations, R01CA312098, 2026–2031, 16 Jun 2026

  • National Cancer Institute

    R01, Family RESPOND: Defining the Genetic Basis of Prostate Cancer Risk in African American Families, R01CA289492, 2025–2030, 5 May 2026

Sources: reporter.nih.gov